Marvin Boris, MD

Articles by Marvin Boris, MD

Persistence of Lymphedema Reduction After Noninvasive Complex Lymphedema Therapy

January 1st 1997

We treated 119 consecutive patients with lymphedema with complex lymphedema therapy (CLT). Lymphedema reductions after CLT averaged 62.6% in the 56 patients with one affected arm and 68.6% in the 38 patients with

Latest Updated Articles

Persistence of Lymphedema Reduction After Noninvasive Complex Lymphedema Therapy
January 1st 1997

Trending on CancerNetwork

FDA Approves Pivekimab Sunirine in Rare Hematologic Malignancy

Anticipated Data and Practice-Changing Trials: An ASCO 2026 Breast Cancer Preview

Toripalimab Regimen Improves EFS, MPR Rate in Stage II/III NSCLC Trial

87 Gedatolisib, a Multitarget PI3K/AKT/mTOR (PAM) Inhibitor, Plus Fulvestrant With or Without Palbociclib for Second-Line (2L) Treatment of Patients With HR+/HER2–/PIK3CA-Wild Type (WT) Advanced Breast Cancer (ABC): Topline Results From VIKTORIA-1